1	Glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
2	receptors	receptor	_	_	_	_	_	_	_
3	are	be	_	_	_	_	_	_	_
4	down-regulated	down-regulate	_	_	_	_	_	_	_
5	in	in	_	_	_	_	_	_	_
6	inflamed	inflamed	_	_	_	_	_	_	_
7	colonic	colonic	_	_	_	_	_	_	_
8	mucosa	mucosa	_	_	_	_	_	_	_
9	but	but	_	_	_	_	_	_	_
10	not	not	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	peripheral	peripheral	_	_	_	_	_	_	_
13	blood	blood	_	_	_	_	_	_	_
14	mononuclear	mononuclear	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	patients	patient	_	_	_	_	_	_	_
18	with	with	_	_	_	_	_	_	_
19	inflammatory	inflammatory	_	_	_	_	_	_	_
20	bowel	bowel	_	_	_	_	_	_	_
21	disease	disease	_	_	_	_	_	_	_
22	[	[	_	_	_	_	_	_	_
23	see	see	_	_	_	_	_	_	_
24	comments	comment	_	_	_	_	_	_	_
25	]	]	_	_	_	_	_	_	_
26	BACKGROUND	BACKGROUND	_	_	_	_	_	_	_
27	:	:	_	_	_	_	_	_	_
28	Growing	grow	_	_	_	_	_	_	_
29	evidence	evidence	_	_	_	_	_	_	_
30	indicates	indicate	_	_	_	_	_	_	_
31	that	that	_	_	_	_	_	_	_
32	the	the	_	_	_	_	_	_	_
33	immune	immune	_	_	_	_	_	_	_
34	system	system	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	the	the	_	_	_	_	_	_	_
37	hypothalamic-pituitary-adrenal	hypothalamic-pituitary-adrenal	_	_	_	_	_	_	_
38	system	system	_	_	_	_	_	_	_
39	are	be	_	_	_	_	_	_	_
40	linked	link	_	_	_	_	_	_	_
41	by	by	_	_	_	_	_	_	_
42	several	several	_	_	_	_	_	_	_
43	mechanisms	mechanism	_	_	_	_	_	_	_
44	,	,	_	_	_	_	_	_	_
45	for	for	_	_	_	_	_	_	_
46	example	example	_	_	_	_	_	_	_
47	intracellular	intracellular	_	_	_	_	_	_	_
48	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
49	receptors	receptor	_	_	_	_	_	_	_
50	(	(	_	_	_	_	_	_	_
51	hGR	hGR	_	_	_	_	_	_	_
52	)	)	_	_	_	_	_	_	_
53	.	.	_	_	_	_	_	_	_

1	Glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
2	are	be	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	standard	standard	_	_	_	_	_	_	_
5	treatment	treatment	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	acute	acute	_	_	_	_	_	_	_
8	attacks	attack	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	inflammatory	inflammatory	_	_	_	_	_	_	_
11	bowel	bowel	_	_	_	_	_	_	_
12	disease	disease	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	IBD	IBD	_	_	_	_	_	_	_
15	)	)	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Binding	binding	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	glucocorticoids	glucocorticoid	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	hGR	hGR	_	_	_	_	_	_	_
6	down-regulates	down-regulate	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	transcription	transcription	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	inflammatory	inflammatory	_	_	_	_	_	_	_
11	genes	gene	_	_	_	_	_	_	_
12	that	that	_	_	_	_	_	_	_
13	can	can	_	_	_	_	_	_	_
14	propagate	propagate	_	_	_	_	_	_	_
15	IBD	ibd	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	PATIENTS	patients	_	_	_	_	_	_	_
2	AND	and	_	_	_	_	_	_	_
3	METHODS	methods	_	_	_	_	_	_	_
4	:	:	_	_	_	_	_	_	_
5	IBD	IBD	_	_	_	_	_	_	_
6	patients	patient	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	either	either	_	_	_	_	_	_	_
9	treated	treat	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	5-60	5-60	_	_	_	_	_	_	_
12	mg	mg	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	prednisolone	prednisolone	_	_	_	_	_	_	_
15	for	for	_	_	_	_	_	_	_
16	more	more	_	_	_	_	_	_	_
17	than	than	_	_	_	_	_	_	_
18	1	1	_	_	_	_	_	_	_
19	week	week	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	were	be	_	_	_	_	_	_	_
22	without	without	_	_	_	_	_	_	_
23	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
24	treatment	treatment	_	_	_	_	_	_	_
25	for	for	_	_	_	_	_	_	_
26	more	more	_	_	_	_	_	_	_
27	than	than	_	_	_	_	_	_	_
28	4	4	_	_	_	_	_	_	_
29	weeks.	weeks.	_	_	_	_	_	_	_
30	hGR	hGR	_	_	_	_	_	_	_
31	levels	level	_	_	_	_	_	_	_
32	were	be	_	_	_	_	_	_	_
33	determined	determine	_	_	_	_	_	_	_
34	from	from	_	_	_	_	_	_	_
35	isolated	isolate	_	_	_	_	_	_	_
36	cytosol	cytosol	_	_	_	_	_	_	_
37	of	of	_	_	_	_	_	_	_
38	peripheral	peripheral	_	_	_	_	_	_	_
39	blood	blood	_	_	_	_	_	_	_
40	mononuclear	mononuclear	_	_	_	_	_	_	_
41	cells	cell	_	_	_	_	_	_	_
42	(	(	_	_	_	_	_	_	_
43	PBMCs	PBMC	_	_	_	_	_	_	_
44	)	)	_	_	_	_	_	_	_
45	or	or	_	_	_	_	_	_	_
46	mucosal	mucosal	_	_	_	_	_	_	_
47	biopsies	biopsy	_	_	_	_	_	_	_
48	using	use	_	_	_	_	_	_	_
49	a	a	_	_	_	_	_	_	_
50	radioassay	radioassay	_	_	_	_	_	_	_
51	with	with	_	_	_	_	_	_	_
52	[	[	_	_	_	_	_	_	_
53	3H]-dexamethasone	3H]-dexamethasone	_	_	_	_	_	_	_
54	.	.	_	_	_	_	_	_	_

1	Interleukin	Interleukin	_	_	_	_	_	_	_
2	(	(	_	_	_	_	_	_	_
3	IL	IL	_	_	_	_	_	_	_
4	)	)	_	_	_	_	_	_	_
5	6	6	_	_	_	_	_	_	_
6	levels	level	_	_	_	_	_	_	_
7	were	be	_	_	_	_	_	_	_
8	determined	determine	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	enzyme-linked	enzyme-linked	_	_	_	_	_	_	_
11	immunosorbent	immunosorbent	_	_	_	_	_	_	_
12	assay	assay	_	_	_	_	_	_	_
13	(	(	_	_	_	_	_	_	_
14	ELISA).	ELISA).	_	_	_	_	_	_	_
15	RESULTS	RESULTS	_	_	_	_	_	_	_
16	:	:	_	_	_	_	_	_	_
17	The	the	_	_	_	_	_	_	_
18	systemic	systemic	_	_	_	_	_	_	_
19	(	(	_	_	_	_	_	_	_
20	PBMC	PBMC	_	_	_	_	_	_	_
21	)	)	_	_	_	_	_	_	_
22	hGR	hGR	_	_	_	_	_	_	_
23	levels	level	_	_	_	_	_	_	_
24	of	of	_	_	_	_	_	_	_
25	corticosteroid-treated	corticosteroid-treated	_	_	_	_	_	_	_
26	IBD	IBD	_	_	_	_	_	_	_
27	patients	patient	_	_	_	_	_	_	_
28	were	be	_	_	_	_	_	_	_
29	significantly	significantly	_	_	_	_	_	_	_
30	lower	low	_	_	_	_	_	_	_
31	than	than	_	_	_	_	_	_	_
32	those	those	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	control	control	_	_	_	_	_	_	_
35	subjects	subject	_	_	_	_	_	_	_
36	(	(	_	_	_	_	_	_	_
37	59.6	59.6	_	_	_	_	_	_	_
38	+/-	+/-	_	_	_	_	_	_	_
39	57.1	57.1	_	_	_	_	_	_	_
40	dpm	dpm	_	_	_	_	_	_	_
41	mg-1	mg-1	_	_	_	_	_	_	_
42	cytosol	cytosol	_	_	_	_	_	_	_
43	protein	protein	_	_	_	_	_	_	_
44	vs.	vs.	_	_	_	_	_	_	_
45	227.0	227.0	_	_	_	_	_	_	_
46	+/-	+/-	_	_	_	_	_	_	_
47	90.8	90.8	_	_	_	_	_	_	_
48	dpm	dpm	_	_	_	_	_	_	_
49	mg-1	mg-1	_	_	_	_	_	_	_
50	cytosol	cytosol	_	_	_	_	_	_	_
51	protein	protein	_	_	_	_	_	_	_
52	,	,	_	_	_	_	_	_	_
53	P	p	_	_	_	_	_	_	_
54	=	=	_	_	_	_	_	_	_
55	0.007	0.007	_	_	_	_	_	_	_
56	)	)	_	_	_	_	_	_	_
57	and	and	_	_	_	_	_	_	_
58	IBD	IBD	_	_	_	_	_	_	_
59	patients	patient	_	_	_	_	_	_	_
60	not	not	_	_	_	_	_	_	_
61	receiving	receive	_	_	_	_	_	_	_
62	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
63	treatment	treatment	_	_	_	_	_	_	_
64	(	(	_	_	_	_	_	_	_
65	179.7	179.7	_	_	_	_	_	_	_
66	+/-	+/-	_	_	_	_	_	_	_
67	171.3	171.3	_	_	_	_	_	_	_
68	dpm	dpm	_	_	_	_	_	_	_
69	mg-1	mg-1	_	_	_	_	_	_	_
70	cytosol	cytosol	_	_	_	_	_	_	_
71	protein	protein	_	_	_	_	_	_	_
72	,	,	_	_	_	_	_	_	_
73	P	p	_	_	_	_	_	_	_
74	=	=	_	_	_	_	_	_	_
75	0.002	0.002	_	_	_	_	_	_	_
76	)	)	_	_	_	_	_	_	_
77	.	.	_	_	_	_	_	_	_

1	Systemic	systemic	_	_	_	_	_	_	_
2	hGR	hGR	_	_	_	_	_	_	_
3	levels	level	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	untreated	untreated	_	_	_	_	_	_	_
6	IBD	IBD	_	_	_	_	_	_	_
7	patients	patient	_	_	_	_	_	_	_
8	did	do	_	_	_	_	_	_	_
9	not	not	_	_	_	_	_	_	_
10	differ	differ	_	_	_	_	_	_	_
11	significantly	significantly	_	_	_	_	_	_	_
12	from	from	_	_	_	_	_	_	_
13	those	those	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	control	control	_	_	_	_	_	_	_
16	subjects	subject	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	patients	patient	_	_	_	_	_	_	_
3	with	with	_	_	_	_	_	_	_
4	connective	connective	_	_	_	_	_	_	_
5	tissue	tissue	_	_	_	_	_	_	_
6	diseases	disease	_	_	_	_	_	_	_
7	,	,	_	_	_	_	_	_	_
8	systemic	systemic	_	_	_	_	_	_	_
9	hGR	hGR	_	_	_	_	_	_	_
10	levels	level	_	_	_	_	_	_	_
11	were	be	_	_	_	_	_	_	_
12	also	also	_	_	_	_	_	_	_
13	found	find	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	be	be	_	_	_	_	_	_	_
16	decreased	decrease	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	absence	absence	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	glucocorticoid	glucocorticoid	_	_	_	_	_	_	_
22	treatment	treatment	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

1	Systemic	systemic	_	_	_	_	_	_	_
2	hGR	hGR	_	_	_	_	_	_	_
3	levels	level	_	_	_	_	_	_	_
4	in	in	_	_	_	_	_	_	_
5	patients	patient	_	_	_	_	_	_	_
6	with	with	_	_	_	_	_	_	_
7	Crohn	Crohn	_	_	_	_	_	_	_
8	â€™s	's	_	_	_	_	_	_	_
9	disease	disease	_	_	_	_	_	_	_
10	(	(	_	_	_	_	_	_	_
11	CD	cd	_	_	_	_	_	_	_
12	)	)	_	_	_	_	_	_	_
13	treated	treat	_	_	_	_	_	_	_
14	with	with	_	_	_	_	_	_	_
15	steroids	steroid	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	66.6	66.6	_	_	_	_	_	_	_
18	+/-	+/-	_	_	_	_	_	_	_
19	61.0	61.0	_	_	_	_	_	_	_
20	dpm	dpm	_	_	_	_	_	_	_
21	mg-1	mg-1	_	_	_	_	_	_	_
22	cytosol	cytosol	_	_	_	_	_	_	_
23	protein	protein	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	were	be	_	_	_	_	_	_	_
26	not	not	_	_	_	_	_	_	_
27	different	different	_	_	_	_	_	_	_
28	from	from	_	_	_	_	_	_	_
29	those	those	_	_	_	_	_	_	_
30	in	in	_	_	_	_	_	_	_
31	patients	patient	_	_	_	_	_	_	_
32	with	with	_	_	_	_	_	_	_
33	ulcerative	ulcerative	_	_	_	_	_	_	_
34	colitis	colitis	_	_	_	_	_	_	_
35	(	(	_	_	_	_	_	_	_
36	UC	UC	_	_	_	_	_	_	_
37	)	)	_	_	_	_	_	_	_
38	(	(	_	_	_	_	_	_	_
39	56.1	56.1	_	_	_	_	_	_	_
40	+/-	+/-	_	_	_	_	_	_	_
41	51.6	51.6	_	_	_	_	_	_	_
42	dpm	dpm	_	_	_	_	_	_	_
43	mg-1	mg-1	_	_	_	_	_	_	_
44	cytosol	cytosol	_	_	_	_	_	_	_
45	protein	protein	_	_	_	_	_	_	_
46	)	)	_	_	_	_	_	_	_
47	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	these	these	_	_	_	_	_	_	_
5	findings	finding	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	mucosal	mucosal	_	_	_	_	_	_	_
8	hGR	hGR	_	_	_	_	_	_	_
9	levels	level	_	_	_	_	_	_	_
10	were	be	_	_	_	_	_	_	_
11	significantly	significantly	_	_	_	_	_	_	_
12	decreased	decrease	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	both	both	_	_	_	_	_	_	_
15	steroid-treated	steroid-treated	_	_	_	_	_	_	_
16	(	(	_	_	_	_	_	_	_
17	18.0	18.0	_	_	_	_	_	_	_
18	+/-	+/-	_	_	_	_	_	_	_
19	15.5	15.5	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	and	and	_	_	_	_	_	_	_
22	not	not	_	_	_	_	_	_	_
23	steroid-treated	steroid-treated	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	37.8	37.8	_	_	_	_	_	_	_
26	+/-	+/-	_	_	_	_	_	_	_
27	30.5	30.5	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	patients	patient	_	_	_	_	_	_	_
30	compared	compare	_	_	_	_	_	_	_
31	with	with	_	_	_	_	_	_	_
32	control	control	_	_	_	_	_	_	_
33	subjects	subject	_	_	_	_	_	_	_
34	(	(	_	_	_	_	_	_	_
35	125.6	125.6	_	_	_	_	_	_	_
36	+/-	+/-	_	_	_	_	_	_	_
37	97.1	97.1	_	_	_	_	_	_	_
38	;	;	_	_	_	_	_	_	_
39	P	p	_	_	_	_	_	_	_
40	=	=	_	_	_	_	_	_	_
41	0.00009	0.00009	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	P	p	_	_	_	_	_	_	_
44	=	=	_	_	_	_	_	_	_
45	0.0008	0.0008	_	_	_	_	_	_	_
46	respectively	respectively	_	_	_	_	_	_	_
47	)	)	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	IL-6	il-6	_	_	_	_	_	_	_
2	levels	level	_	_	_	_	_	_	_
3	in	in	_	_	_	_	_	_	_
4	all	all	_	_	_	_	_	_	_
5	IBD	ibd	_	_	_	_	_	_	_
6	groups	group	_	_	_	_	_	_	_
7	with	with	_	_	_	_	_	_	_
8	and	and	_	_	_	_	_	_	_
9	without	without	_	_	_	_	_	_	_
10	steroids	steroid	_	_	_	_	_	_	_
11	were	be	_	_	_	_	_	_	_
12	significantly	significantly	_	_	_	_	_	_	_
13	different	different	_	_	_	_	_	_	_
14	from	from	_	_	_	_	_	_	_
15	those	those	_	_	_	_	_	_	_
16	in	in	_	_	_	_	_	_	_
17	control	control	_	_	_	_	_	_	_
18	subjects	subject	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	CONCLUSION	conclusion	_	_	_	_	_	_	_
2	:	:	_	_	_	_	_	_	_
3	In	in	_	_	_	_	_	_	_
4	IBD	IBD	_	_	_	_	_	_	_
5	there	there	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	no	no	_	_	_	_	_	_	_
8	difference	difference	_	_	_	_	_	_	_
9	in	in	_	_	_	_	_	_	_
10	systemic	systemic	_	_	_	_	_	_	_
11	hGR	hGR	_	_	_	_	_	_	_
12	levels	level	_	_	_	_	_	_	_
13	between	between	_	_	_	_	_	_	_
14	not	not	_	_	_	_	_	_	_
15	steroid-treated	steroid-treated	_	_	_	_	_	_	_
16	patients	patient	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	control	control	_	_	_	_	_	_	_
19	subjects	subject	_	_	_	_	_	_	_
20	,	,	_	_	_	_	_	_	_
21	in	in	_	_	_	_	_	_	_
22	spite	spite	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	inflammatory	inflammatory	_	_	_	_	_	_	_
25	activity	activity	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	IL-6	IL-6	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	Mucosal	mucosal	_	_	_	_	_	_	_
2	hGR	hGR	_	_	_	_	_	_	_
3	levels	level	_	_	_	_	_	_	_
4	were	be	_	_	_	_	_	_	_
5	decreased	decrease	_	_	_	_	_	_	_
6	independently	independently	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	treatment	treatment	_	_	_	_	_	_	_
9	,	,	_	_	_	_	_	_	_
10	probably	probably	_	_	_	_	_	_	_
11	leading	lead	_	_	_	_	_	_	_
12	to	to	_	_	_	_	_	_	_
13	a	a	_	_	_	_	_	_	_
14	decreased	decrease	_	_	_	_	_	_	_
15	protection	protection	_	_	_	_	_	_	_
16	against	against	_	_	_	_	_	_	_
17	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
18	action	action	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	intestinal	intestinal	_	_	_	_	_	_	_
22	mucosa	mucosa	_	_	_	_	_	_	_
23	.	.	_	_	_	_	_	_	_

